🔎 Trials Near Me

Hem › Crohns sjukdom › Massachusetts

Kliniska studier för Crohns sjukdom i Massachusetts

27 studier för Crohns sjukdom söker deltagare vid platser i Massachusetts.

Städer i Massachusetts

Officiell studietext (engelska)

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • Massachusetts General Hospital-Crohn's and Colitis Center ( Site 5037), Boston
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Lucida Clinical Trials /ID# 282000, New Bedford
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07697456

Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance

  • Massachusetts General Hospital, Boston
RekryterarFriska volontärer välkomna
Ålder 18 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07033208

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Gastro Health Research - Framingham, Framingham
  • Lucida Clinical Trials LLC, New Bedford
RekryterarFas 4
Ålder 18 till 80 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06581328

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Boston Childrens Hospital, Boston
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 25 sep. 2026 · NCT05923073

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  • Lucida Clinical Trials /ID# 266548, New Bedford
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06548542

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  • Lucida Clinical Trials, New Bedford
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07499232

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Lucida Clinical Trials, New Bedford
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937099

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT03816345

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Tufts Medical Center-Site Number: 8400126, Boston
  • UMass Memorial Medical Center-Site Number: 8400121, Worcester
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Massachusetts General Hospital - Mass General Waltham /ID# 255767, Waltham
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 23 sep. 2026 · NCT05995353

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Boston Children's Hospital, Boston
  • Massachusetts General Hospital, Waltham
RekryterarFas 3
Ålder 2 till 19 · Alla kön · Uppdaterad 22 sep. 2026 · NCT04844606

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

  • Boston Children's Hospital, Boston
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 24 aug. 2026 · NCT05509777

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  • Brigham and Women's Hospital, Boston
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 5 aug. 2026 · NCT07237516

Low Dose IL-2 for the Treatment of Crohn's Disease

  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
RekryterarFas 1/2
Ålder 12 till 80 · Alla kön · Uppdaterad 3 aug. 2026 · NCT04263831

Cranberry and Gut Health in Crohn's Disease

  • UMASS medical center, Worcester
RekryterarTidig fas 1
Ålder 18 till 65 · Alla kön · Uppdaterad 20 juli 2026 · NCT07170462

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

  • Boston Children's Hospital /ID# 262191, Boston
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 24 juni 2026 · NCT06332534

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

  • Boston Children's Hospital, Boston
RekryterarFas 4
Ålder 6 till 17 · Alla kön · Uppdaterad 27 maj 2026 · NCT05781152

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

  • Boston Children's Hospital, Boston
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 5 maj 2026 · NCT04779320

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

  • Lucida Clinical Trials, LLC, New Bedford
  • University of Massachusetts, Worcester, Worcester
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 27 apr. 2026 · NCT06456593

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

  • Investigational Site Number: 8400022, Boston
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 27 mars 2026 · NCT06958536

Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.

  • Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown
RekryterarObservationsstudie
Ålder 18 till 99 · Alla kön · Uppdaterad 12 mars 2026 · NCT06252493

Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility

  • Massachusetts General Hospital, Boston
RekryterarFriska volontärer välkomna
Ålder 14 och äldre · Alla kön · Uppdaterad 30 jan. 2026 · NCT05332639

A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule

  • Massachusetts General Hospital, Boston
RekryterarFriska volontärer välkomna
Ålder 18 till 75 · Alla kön · Uppdaterad 16 dec. 2025 · NCT07219537

Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

  • Boston Children's Hospital, Boston
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 13 till 20 · Alla kön · Uppdaterad 30 okt. 2025 · NCT04508088

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

  • Boston Children's Hospital, Boston
RekryterarObservationsstudie
Ålder 5 till 25 · Alla kön · Uppdaterad 3 mars 2025 · NCT04331639

Family Members At INcreased-risk for Developing Inflammatory Bowel Disease

  • Massachusetts General Hospital, Boston
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 14 och äldre · Alla kön · Uppdaterad 20 dec. 2024 · NCT06655415

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.